Emerging data is showing that treatment within 6 months of presentation of multiple sclerosis (MS) is ideal, explained Patricia K. Coyle, MD, of Stony Brook University Neurosciences Institute.
The time from symptom onset to diagnosis can be a year or 2 years, which is a concern when emerging data is showing that treatment within 6 months of presentation is ideal , explained Patricia K. Coyle, MD, director of the MS Comprehensive Care Center and professor of neurology at Stony Brook University Neurosciences Institute.
Transcript
There is a push to diagnose multiple sclerosis earlier. Currently, what is the typical time from symptom onset to diagnosis?
Surprisingly, it can be a year or 2. It can be quite a lag phase. I think that's why people have to recognize the suggestive features for MS, understand there should be a robust laboratory workup, and apply the 2017 McDonald diagnostic criteria. It's been shown that there's a gap in knowledge about those formal criteria, both among MS experts and neurology residents in the United States. We need to really get our act together and be very familiar and use those formal diagnostic criteria.
Early treatment of multiple sclerosis is better, but how much better?
The data is clearly, steadily accumulating that a group of MS patients who are treated earlier compared to a group that are somewhat delayed, the early treatment is doing better. And that's a consistent finding of every single study.
And actually, the first couple of months may be critical. Very akin to rheumatoid arthritis, where they have great data that after the presentation, if you don't institute treatment, within 3 to 6 months, that person will have permanent bone and joint injury several years later. I think we're getting accumulating evidence from MS that you really do want to treat within, ideally, 6 months of presentation.
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen